Health Economics›Alveolar soft part sarcoma›All lines of therapy

All lines of therapy

Alveolar soft part sarcoma · 1 regimen

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

Filters

Y-axis

Cost vs Efficacy · 1 point

Fully pricedPartial pricing

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
Atezolizumab monotherapy Variant #01	—	R 31 255	21d	~12.9 mo	~13.3 mo	~19	~R 593 838 PFS proxy · indirect	10

1 of 1 regimen shown